Journal
NEUROLOGY
Volume 84, Issue 5, Pages 490-495Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0000000000001214
Keywords
-
Categories
Funding
- Ipsen [NCT01696708]
- Institut National de la Sante et de la Recherche Medicale [NCT01882062]
- program Investissements d'avenir [ANR-10-IAIHU-06]
- NIH [P41 EB015894, P30 NS076408]
Ask authors/readers for more resources
Objective:Based on our previous work in Huntington disease (HD) showing improved energy metabolism in muscle by providing substrates to the Krebs cycle, we wished to obtain a proof-of-concept of the therapeutic benefit of triheptanoin using a functional biomarker of brain energy metabolism validated in HD.Methods:We performed an open-label study using P-31 brain magnetic resonance spectroscopy (MRS) to measure the levels of phosphocreatine (PCr) and inorganic phosphate (Pi) before (rest), during (activation), and after (recovery) a visual stimulus. We performed P-31 brain MRS in 10 patients at an early stage of HD and 13 controls. Patients with HD were then treated for 1 month with triheptanoin after which they returned for follow-up including P-31 brain MRS scan.Results:At baseline, we confirmed an increase in Pi/PCr ratio during brain activation in controlsreflecting increased adenosine triphosphate synthesisfollowed by a return to baseline levels during recovery (p = 0.013). In patients with HD, we validated the existence of an abnormal brain energy profile as previously reported. After 1 month, this profile remained abnormal in patients with HD who did not receive treatment. Conversely, the MRS profile was improved in patients with HD treated with triheptanoin for 1 month with the restoration of an increased Pi/PCr ratio during visual stimulation (p = 0.005).Conclusion:This study suggests that triheptanoin is able to correct the bioenergetic profile in the brain of patients with HD at an early stage of the disease.Classification of evidence:This study provides Class III evidence that, for patients with HD, treatment with triheptanoin for 1 month restores an increased MRS Pi/PCr ratio during visual stimulation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available